-
1
-
-
0041358796
-
Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies
-
T.A. Ciulla, A.G. Amador, and B. Zinman Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies Diabetes Care. 26 2003 2653 2664
-
(2003)
Diabetes Care.
, vol.26
, pp. 2653-2664
-
-
Ciulla, T.A.1
Amador, A.G.2
Zinman, B.3
-
2
-
-
84894084870
-
Management paradigms for diabetic macular edema
-
P. Mitchell, and T.Y. Wong Management paradigms for diabetic macular edema Am J Ophthalmol. 157 2014 505 513
-
(2014)
Am J Ophthalmol.
, vol.157
, pp. 505-513
-
-
Mitchell, P.1
Wong, T.Y.2
-
3
-
-
84883775340
-
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema
-
D.G. Callanan, S. Gupta, D.S. Boyer, T.A. Ciulla, M.A. Singer, B.D. Kuppermann, and et al. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema Ophthalmology. 120 2013 1843 1851
-
(2013)
Ophthalmology.
, vol.120
, pp. 1843-1851
-
-
Callanan, D.G.1
Gupta, S.2
Boyer, D.S.3
Ciulla, T.A.4
Singer, M.A.5
Kuppermann, B.D.6
-
4
-
-
33845191304
-
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
-
Q.D. Nguyen, S. Tatlipinar, S.M. Shah, J.A. Haller, E. Quinlan, J. Sung, and et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol. 142 2006 961 969
-
(2006)
Am J Ophthalmol.
, vol.142
, pp. 961-969
-
-
Nguyen, Q.D.1
Tatlipinar, S.2
Shah, S.M.3
Haller, J.A.4
Quinlan, E.5
Sung, J.6
-
5
-
-
84885022310
-
Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE extension study
-
G.E. Lang, A. Berta, B.M. Eldem, C. Simader, D. Sharp, F.G. Holz, and et al. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE extension study Ophthalmology. 120 2013 2004 2012
-
(2013)
Ophthalmology.
, vol.120
, pp. 2004-2012
-
-
Lang, G.E.1
Berta, A.2
Eldem, B.M.3
Simader, C.4
Sharp, D.5
Holz, F.G.6
-
6
-
-
84885022258
-
Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from 2 phase III trials: RISE and RIDE
-
D.M. Brown, Q.D. Nguyen, D.M. Marcus, D.S. Boyer, S. Patel, L. Feiner, and et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from 2 phase III trials: RISE and RIDE Ophthalmology. 120 2013 2013 2022
-
(2013)
Ophthalmology.
, vol.120
, pp. 2013-2022
-
-
Brown, D.M.1
Nguyen, Q.D.2
Marcus, D.M.3
Boyer, D.S.4
Patel, S.5
Feiner, L.6
-
7
-
-
77952779304
-
Randomized trial evaluating ranibizumab plusprompt laser for diabetic macular edema
-
M.J. Elman, L.P. Aiello, R.W. Beck, N.M. Bressler, S.B. Bressler, A.R. Edwards, and et al. Randomized trial evaluating ranibizumab plusprompt laser for diabetic macular edema Ophthalmology. 117 2010 1064 1077
-
(2010)
Ophthalmology.
, vol.117
, pp. 1064-1077
-
-
Elman, M.J.1
Aiello, L.P.2
Beck, R.W.3
Bressler, N.M.4
Bressler, S.B.5
Edwards, A.R.6
-
8
-
-
82755164498
-
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema
-
L.P. Aiello, R.W. Beck, N.M. Bressler, D.J. Browning, K.V. Chalam, M. Davis, and et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema Ophthalmology 2011 118
-
(2011)
Ophthalmology
, pp. 118
-
-
Aiello, L.P.1
Beck, R.W.2
Bressler, N.M.3
Browning, D.J.4
Chalam, K.V.5
Davis, M.6
-
9
-
-
84868208071
-
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results
-
M.J. Elman, H. Qin, L.P. Aiello, R.W. Beck, N.M. Bressler, F.L. Ferris, and et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results Ophthalmology. 119 2012 2312 2318
-
(2012)
Ophthalmology.
, vol.119
, pp. 2312-2318
-
-
Elman, M.J.1
Qin, H.2
Aiello, L.P.3
Beck, R.W.4
Bressler, N.M.5
Ferris, F.L.6
-
10
-
-
84983056928
-
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
-
E. Pacella, A.R. Vestri, R. Muscella, M.R. Carbotti, M. Castellucci, L. Coi, and et al. Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema Clin Ophthalmol. 7 2013 1423 1428
-
(2013)
Clin Ophthalmol.
, vol.7
, pp. 1423-1428
-
-
Pacella, E.1
Vestri, A.R.2
Muscella, R.3
Carbotti, M.R.4
Castellucci, M.5
Coi, L.6
-
11
-
-
84864601616
-
Intravitreal dexamethasone implant in patients with persistent diabetic macular edema
-
I. Zucchiatti, R. Lattanzio, G. Querques, C. del Turco, M.L. Cascavilla, and F. Bandello Intravitreal dexamethasone implant in patients with persistent diabetic macular edema Ophthalmologica. 228 2012 117 122
-
(2012)
Ophthalmologica.
, vol.228
, pp. 117-122
-
-
Zucchiatti, I.1
Lattanzio, R.2
Querques, G.3
Del Turco, C.4
Cascavilla, M.L.5
Bandello, F.6
-
12
-
-
77749330682
-
Dexamethasone DDS Phase II Study Group: Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema
-
J.A. Haller, B.D. Kuppermann, M.S. Blumenkranz, G.A. Williams, D.V. Weinberg, C. Chou, and et al. Dexamethasone DDS Phase II Study Group: Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol. 128 2010 289 296
-
(2010)
Arch Ophthalmol.
, vol.128
, pp. 289-296
-
-
Haller, J.A.1
Kuppermann, B.D.2
Blumenkranz, M.S.3
Williams, G.A.4
Weinberg, D.V.5
Chou, C.6
-
13
-
-
80052857441
-
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results
-
J.A. Haller, F. Bandello, R. Belfort Jr., M.S. Blumenkranz, M. Gillies, J. Heier, and et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results Ophthalmology. 118 2011 2453 2460
-
(2011)
Ophthalmology.
, vol.118
, pp. 2453-2460
-
-
Haller, J.A.1
Bandello, F.2
Belfort Jr, . R.3
Blumenkranz, M.S.4
Gillies, M.5
Heier, J.6
|